Towa Pharmaceutical Reports Strong Sales but Decline in Profit

Towa Pharmaceutical Co (JP:4553) has released an update.

Towa Pharmaceutical Co. reported a strong financial performance for the first half of 2024, with a 14.9% increase in net sales and a significant 50.1% rise in operating profit compared to the previous year. However, profit attributable to owners of the parent decreased by 5.7%, indicating some financial challenges despite overall growth.

For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.